The Nebivolol action on vascular tone is dependent on actin cytoskeleton polymerization and Rho-A activity into ECs and SMCs

Abstract : Nitric oxide is implicated in the target action of Nebivolol, a selective beta 1 adrenoceptor blocker used in hypertension treatment. As the Nitric Oxide (NO) production and the actin cytoskeleton are linked, the aim of this work was to study the involvement of actin cytoskeleton on mechanism of action of Nebivolol in cultured endothelial cells. We studied the effect of Nebivolol (200 mu M) on actin filaments remodeling and its impact on NO production and eNOS activation. Results showed that Nebivolol perturbs actin filaments polymerization, increases NO production and eNOS activity between 30 minutes and 1 h. Stabilization of actin filaments with phalloidine (50 mu M) abolishes Nebivolol effects on eNOS activation and NO production. Furthermore, Rho-kinase activity decreased during the first hour of Nebivolol treatment, then increased after 3 h, while actin filaments repolymerized, eNOS activation and NO production decreased. In SMCs, Nebivolol induced a decrease in the Rhokinase activity from 1 h until 24 h of incubation. In conclusion, we suggest that Nebivolol induced NO production in Endothelial Cells (ECs) via complementary actions between actin cytoskeleton remodeling inducing eNOS activation and Rho-kinase implication. The effect of Nebivolol on ECs occurs during the first hour, this effect on SMCs seems to be maintained until 24 h, explaining persisted action of Nebivolol observed in vivo.
Type de document :
Article dans une revue
Clinical Hemorheology and Microcirculation, IOS Press, 2014, 56 (3), pp.231-246. 〈10.3233/CH-131718〉
Liste complète des métadonnées

https://hal.univ-lorraine.fr/hal-01453203
Contributeur : Imopa Ul <>
Soumis le : jeudi 2 février 2017 - 16:12:32
Dernière modification le : samedi 7 avril 2018 - 01:28:17

Identifiants

Citation

A. Kadi, N. Isla, V. Moby, P. Lacolley, P. Labrude, et al.. The Nebivolol action on vascular tone is dependent on actin cytoskeleton polymerization and Rho-A activity into ECs and SMCs. Clinical Hemorheology and Microcirculation, IOS Press, 2014, 56 (3), pp.231-246. 〈10.3233/CH-131718〉. 〈hal-01453203〉

Partager

Métriques

Consultations de la notice

43